Safety and Tolerability of Open-Labeled Iloperidone in Adolescents

Clinical trial NCT05648591 · RECRUITING

Trial details

NCT number: NCT05648591
Sponsor: Vanda Pharmaceuticals
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Schizophrenia Bipolar I Disorder

Start date: 2023-05-24
Primary completion: 2026-03-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.